Skip to Main Content

Paper Details

Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma.
Neuro Oncol
30
2021
1p/19q non, CDKN2A/B, CNV, DNA, DNA methylation, IDH1, IDH1/2, IDH1/2mt, PDGFRA, PI3K mutations, anaplastic astrocytoma, anaplastic astrocytomas, anaplastic glioma, genome, glioma, microvascular proliferation, patient, patients, temozolomide, tumor, tumors
Author NameAffiliation
Marc SansonSorbonne Universite, Hopitaux Universitaires La Pitie Salpetriere
Michael A VogelbaumMoffitt Cancer Center
Warren P MasonPrincess Margaret Cancer Centre
C Leland Rogers
Michael WellerUniversity Hospital of Zurich
Thais S Sabedot
Youri Hoogstrate
Andreas von DeimlingRuprecht-Karls-University
Andreas von DeimlingClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
Kenneth AldapePrincess Margaret Cancer Centre
Kenneth AldapePrincess Margaret Cancer Centre
Johan M Kros
Houtan Noushmehr
Houtan Noushmehr
Pim J French
  • 1 - 15

Datasets

Release 1.2